STOCK TITAN

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Akoya Biosciences, Inc. (Nasdaq: AKYA) will report its first-quarter 2024 financial results on May 13th, 2024. The company will host a conference call at 5:00 p.m. ET to discuss the results. Investors can register online to listen to the call and access the webcast on the Akoya website.
Akoya Biosciences, Inc. (Nasdaq: AKYA) comunicherà i risultati finanziari del primo trimestre del 2024 il 13 maggio 2024. L'azienda terrà una conferenza telefonica alle 17:00 ET per discutere i risultati. Gli investitori possono registrarsi online per ascoltare la chiamata e accedere al webcast sul sito web di Akoya.
Akoya Biosciences, Inc. (Nasdaq: AKYA) informará sobre sus resultados financieros del primer trimestre de 2024 el 13 de mayo de 2024. La compañía organizará una llamada de conferencia a las 5:00 p.m. ET para discutir los resultados. Los inversores pueden registrarse en línea para escuchar la llamada y acceder a la transmisión web en el sitio web de Akoya.
아코야 바이오사이언스, Inc. (나스닥: AKYA)는 2024년 1분기 재무 결과를 2024년 5월 13일에 보고할 예정입니다. 회사는 결과를 논의하기 위해 동부 표준시 오후 5시에 컨퍼런스 콜을 개최할 것입니다. 투자자는 Akoya 웹사이트에서 웹캐스트에 접속하고 콜을 듣기 위해 온라인으로 등록할 수 있습니다.
Akoya Biosciences, Inc. (Nasdaq: AKYA) rapportera ses résultats financiers pour le premier trimestre 2024 le 13 mai 2024. La société organisera une conférence téléphonique à 17h00 ET pour discuter des résultats. Les investisseurs peuvent s'inscrire en ligne pour écouter l'appel et accéder à la webdiffusion sur le site Web d'Akoya.
Akoya Biosciences, Inc. (Nasdaq: AKYA) wird seine Finanzergebnisse für das erste Quartal 2024 am 13. Mai 2024 bekannt geben. Das Unternehmen wird um 17:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können sich online registrieren, um den Anruf zu hören und den Webcast auf der Akoya-Website zu verfolgen.
Positive
  • None.
Negative
  • None.

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the first quarter of 2024 after the market close on May 13th, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences

As The Spatial Biology Company®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
investors@akoyabio.com

Media Contact:
Christine Quern
media@akoyabio.com


FAQ

When will Akoya Biosciences report its first-quarter 2024 financial results?

Akoya Biosciences will report its first-quarter 2024 financial results on May 13th, 2024.

What is the ticker symbol for Akoya Biosciences?

The ticker symbol for Akoya Biosciences is AKYA.

What time will the conference call to discuss financial results be held?

The conference call to discuss financial results will be held at 5:00 p.m. ET.

Where can investors access the live and archived webcast of the event?

Investors can access the live and archived webcast of the event on the 'Investors' section of the Akoya website at https://investors.akoyabio.com/.

Akoya BioSciences, Inc.

NASDAQ:AKYA

AKYA Rankings

AKYA Latest News

AKYA Stock Data

199.50M
17.38M
12.87%
72.24%
2.01%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
MARLBOROUGH

About AKYA

akoya biosciences is developing a novel high-parameter tissue analysis platform, at an order of magnitude beyond what is currently possible. our codex (tm) (co-detection by indexing) system enables deep proteomic profiling.​..all on your existing microscope​. if you are a scientist or software engineer interested in revolutionizing the science of imaging, then akoya is the place for you. contact is at info@akoyabio.com.